FDA cleared the Metrix COVID Test; Metrix COVID Test Pro from Aptitude Medical Systems, Inc. on Aug 7, 2026 under K253453, a traditional 510(k). The device falls under product code QWB, Over-The-Counter Molecular Test To Detect Sars-Cov-2 From Clinical Specimens, regulated at 21 CFR 866.3984 as a Class 2 device. The review panel was Microbiology.

FDA logged the submission as received on Oct 6, 2025. The decision came 305 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

This is the only decision on file for Aptitude Medical Systems, Inc. in the last 12 months of the tracker.